RXRX: Recursion Pharmaceuticals Inc - Class A
RXRX exchange rate has changed by -0.55% for today. During the day, the instrument was traded at a low of 3.56 and at a high of 3.76.
Follow Recursion Pharmaceuticals Inc - Class A dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
RXRX News
- Recursion Pharmaceuticals (RXRX) Surpasses Market Returns: Some Facts Worth Knowing
- Needham Reiterates Buy on Recursion Pharmaceuticals, Maintains $8 Price Target
- Recursion Pharmaceuticals (RXRX) Stock is Trending After Hours: Here’s What You Should Know
- Recursion: REC-4881 End 2026 Program Update And Collaboration Candidates In Play (RXRX)
- Recursion Announces Sanofi Option Of First Immunology Drug Candidate, Triggering $10M Milestone Payment And Potential Phase 1 Trials In 2027
- Recursion Pharmaceuticals (RXRX) Registers a Bigger Fall Than the Market: Important Facts to Note
- Tempus AI Expands Strategic Collaborations to Drive Future Growth
- Recursion Pharmaceuticals (RXRX) Stock Declines While Market Improves: Some Information for Investors
- Cathie Wood's $22M Biotech Shuffle, Dumps One Stock for 21st Straight Session While Other Bets Pile Up
- 'HHS launches project to speed up clinical trials' - Axios
- Beam Therapeutics: Ignore The Anthropic Noise And Focus On Clinical Progress (NASDAQ:BEAM)
- Recursion Pharmaceuticals (RXRX) Registers a Bigger Fall Than the Market: Important Facts to Note
- Squeeze Watch: 10 Stocks With Over 33% Short Interest
- Can Recursion Pharmaceuticals' Strategic Deals Fuel Long-Term Growth?
- Recursion Pharmaceuticals (RXRX) Stock Moves 2.02%: What You Should Know
- Tempus AI Extends Recursion Data Deal Through 2029, Replacing Potential $84M Fees With $42M In Committed Payments, In Addition To Licensing Recursion’s RNA Foundation Model "TxFM" Under A Separate License Agreement
- FDA Grants Priority Review to AZN's Filing for Rare Bone Disease Drug
- Recursion Pharmaceuticals Reports Q2 2026 Results: Full Earnings Call Transcript
- Recursion Pharmaceuticals (RXRX) Falls More Steeply Than Broader Market: What Investors Need to Know
Frequently Asked Questions
What is RXRX stock price today?
Recursion Pharmaceuticals Inc - Class A stock is priced at 3.64 today. It trades within 3.56 - 3.76, yesterday's close was 3.66, and trading volume reached 15989. The live price chart of RXRX shows these updates.
Does Recursion Pharmaceuticals Inc - Class A stock pay dividends?
Recursion Pharmaceuticals Inc - Class A is currently valued at 3.64. Dividend policy depends on the company, while investors also watch -34.41% and USD. View the chart live to track RXRX movements.
How to buy RXRX stock?
You can buy Recursion Pharmaceuticals Inc - Class A shares at the current price of 3.64. Orders are usually placed near 3.64 or 3.94, while 15989 and -0.27% show market activity. Follow RXRX updates on the live chart today.
How to invest into RXRX stock?
Investing in Recursion Pharmaceuticals Inc - Class A involves considering the yearly range 2.77 - 5.76 and current price 3.64. Many compare -10.34% and 5.20% before placing orders at 3.64 or 3.94. Explore the RXRX price chart live with daily changes.
What are Recursion Pharmaceuticals Inc - Class A stock highest prices?
The highest price of Recursion Pharmaceuticals Inc - Class A in the past year was 5.76. Within 2.77 - 5.76, the stock fluctuated notably, and comparing with 3.66 helps spot resistance levels. Track Recursion Pharmaceuticals Inc - Class A performance using the live chart.
What are Recursion Pharmaceuticals Inc - Class A stock lowest prices?
The lowest price of Recursion Pharmaceuticals Inc - Class A (RXRX) over the year was 2.77. Comparing it with the current 3.64 and 2.77 - 5.76 shows potential long-term entry points. Watch RXRX moves on the chart live for more details.
When did RXRX stock split?
Recursion Pharmaceuticals Inc - Class A has gone through stock splits historically. These changes are visible in , 3.66, and -34.41% after corporate actions.
- Previous Close
- 3.66
- Open
- 3.65
- Bid
- 3.64
- Ask
- 3.94
- Low
- 3.56
- High
- 3.76
- Volume
- 15.989 K
- Daily Change
- -0.55%
- Month Change
- -10.34%
- 6 Months Change
- 5.20%
- Year Change
- -34.41%
- Act
- Fcst
- 198 K
- Prev
- 199 K
- Act
- Fcst
- 1.723 M
- Prev
- 1.710 M
- Act
- Fcst
- 0.0%
- Prev
- -0.1%
- Act
- Fcst
- Prev
- 1.955%